#RBC

  • Hong Kong researchers discover new antiviral strategy to treat COVID-19

    The University of Hong Kong on Monday announced that a class of metallodrugs currently used in the treatment of other infectious diseases can potently suppress the SARS-CoV-2 virus that causes COVID-19.

    According to researchers from the university, ranitidine bismuth citrate (RBC), a commonly used anti-ulcer drug which contains the metal Bismuth, has been demonstrated to greatly reduce viral loads by over 1,000-folds in SARS-CoV-2-infected cells.

Partners